ClinicalTrials.govpublic full text
T Cell Inflamed Gene Expression Profiling Score-guided Anti PD-1 Therapy (Tislelizumab Monotherapy) for Refractory Solid Cancer Patients Unexposed to Immunotherapy
refractory solid cancer patients unexposed to immunotherapy
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 154647
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.